Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
NY Times Article Fails the Test in Sensational Report
cross-posted from MGH PD webforum: ------------------------------------------------------------- Topic: NY Times Article Fails the Test in Sensational Report Author: GregM Posted: March 08, 2001 06:46 PM ------------------------------------------------------------- Ok, I gotta ask. What was Gina Kolata thinking about about when she penned that hit piece on what was admittedly a disappointing report from Dr. Freed of the Univ. of Colo.? The reports are mixed, with her's being the most pessimistic. But why, in a major piece in a nationally read newspaper was there no mention of that fact that the techniques used in the study were three years old, a lifetime in terms of embryonic stem cell research? She could have discussed in at least some detail the fact this was the first controlled human study. It was unlikely to hit a bulls-eye first shot out of the box. Lessons are learned and we go on. No less an authority than William Langston of the Parkinson's Institute is quoted as saying that stem cell therapy still holds the greatest promise as a therapy for PD. Why was there no follow-up to that statement, like "why do you say that." And, perhaps most egregious and indicative of the reporter's knowledge about stem cell research, there was no mention at all of the following report in which the Head of the Parkinson's Center for Excellence at Harvard, Dr. Ole Isacson, and Dr. Ronald McKay of NIH, separately announced that they had "cured" PD in lab animals? I would think that the extreme juxtaposition of these research results would have spurred any reporter to dig deeper into the story. I have to believe that their dramatic announcement indicates that the Isacson/Mckay results are not simply due to the fact that lab rats aren't human (which obviously can be a stumbling block and animal studies don't always pan out). Different techniques were used by each Dr., using embryonic stem cells. If they differed from one another, my guess is that those techniques also differed, perhaps dramatically, from those use by Dr. Freed in Colorado who began his project with the information available to him at that time. Lastly, the NY Times article focused irresponsibly on the controversial "control" technique of placebo operations on volunteers. First, advisable or not, it has nothing to do with the results, ostensibly the purpose of the article. Second, these volunteers averaged fourteen years post-dx, and knew the risks when they signed what I presume was a massive consent form. That may seem like cold comfort when those who voluntarily participate to further the progress of science suffer rather reap a benefit, but again the article caricatures them as if they were Chinese prisoners and not willing and knowledgable participants. Finally, the article even implies that Freed and his colleagues pulled a fast one as to patient fees. I seriously doubt that Dr. Stanley Fahn of Columbia (one of scientist conducting this project), a world renowned Parkinson's specialist, was cooking the books. 80 Nobel Laureates didn't fax a letter to President Bush urging continuation of this line of research because they had nothing better to due between lunch and dinner. My guess is that the next few days will see other more balanced articles in response to the Times and wire service stories. For the record, this report below from Feb. 16 is unexplainably omitted from any mention. Read it and take heart. One trial report at the three-year mark does not spell the end of what is "still the most promising line of therapuetic inquiry (Dr. William Langston)." Greg -------------------------- Embryonic Stem Cell Transplants Reverse Symptoms in Mice ASSOCIATED PRESS SAN FRANCISCO, Feb. 16 - Scientists may be on the brink of curing Parkinson's disease using transplanted embryonic stem cells, but where and when that new treatment is tested in humans depends on unresolved political decisions, researchers suggested Friday. DR. OLE Isacson of Harvard Medical School and Dr. Ronald McKay of the National Institutes of Health said Friday they have both "cured" Parkinson's in mice and rats, using stem cells removed from embryos of laboratory animals. .... SNIP .... -------------------------- IP: Logged ------------------------------------------------------------- from linda5 posted March 08, 2001 07:19 PM ------------------------------------------------------------- Greg, I am in complete agreement with your post...80 nobel prize winners must have a better collective idea of where hope ...compared to the average reporter...if they feel this research shows hope so do I...Linda IP: Logged ------------------------------------------------------------- from janet313313 posted March 08, 2001 07:16 PM ------------------------------------------------------------- thank you for this, greg if you don't mind, i would like to post your comments to the PARKINSN listserv group i, too, found myself wondering why the time frame was never mentioned and was taken aback by all the 'disaster' talk. i wonder what's going on behind the scenes... janet IP: Logged ------------------------------------------------------------- from GregM posted March 08, 2001 07:20 PM ------------------------------------------------------------- Janet, Start that crossposting! Your pal, Greg ------------------------------------------------------------- janet paterson, an akinetic rigid subtype parkie 53 now / 44 dx cd / 43 onset cd / 41 dx pd / 37 onset pd TEL: 613 256 8340 SMAIL: PO Box 171 Almonte Ontario K0A 1A0 Canada EMAIL: janet313@xxxxxxxxxxx URL:
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance